HYEX / Healthy Extracts Inc. - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 HEALTHY EXTRACTS INC. (Exa

Membership Interest Purchase Agreement with Gummy USA LLC dated July 19, 2025

MEMBERSHIP INTEREST PURCHASE AGREEMENT This Membership Interest Purchase Agreement (this “Agreement”) is entered into on July 19, 2025 (the “Effective Date”) by and among Healthy Extracts Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2025 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55572 (Commission File Number) 47-

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 HEALTHY EXTRACTS INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc. (E

UNITED STATES

Renewable Innovations 10-Q Late Notice 2.28.23 (02127246).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-5572 Washington, D.C. 20549 CUSIP No: 42227D 20 9 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: December 31, 2024 ¨ Transition report on Form 10-K ¨ Transition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 HEALTHY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-5572 Washington, D.

Second Amendment to 10% OID Promissory Note

SECOND AMENDMENT TO 10% OID PROMISSORY NOTE This Second Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on May 3, 2024 (the “Execution Date”) and effective as of April 24, 2024 (the “Effective Date”) by and between Healthy Extracts, Inc.

May 10, 2024

May 10, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2024 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-2

Second Amendment to 10% OID Promissory Note

SECOND AMENDMENT TO 10% OID PROMISSORY NOTE This Second Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on April 23rd, 2024 (the “Execution Date”) and effective as of April 24, 2024 (the “Effective Date”) by and between Healthy Extracts, Inc.

Termination of a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2024 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number

Certificate of Amendment of Articles of Incorporation filed December 19, 2023

HE ArtAmend re Split (01956118-5).DOCX CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of HEALTHY EXTRACTS INC. The undersigned hereby certifies: 1. The name of the Corporation is Healthy Extracts Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: “Article 3, Authorized Stock: The Corporation has the authority to issue Fifty Million (50,000,000)

As filed with the Securities and Exchange Commission on November 22, 2023

As filed with the Securities and Exchange Commission on November 22, 2023 Registration No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc.

First Amendment to 10% OID Promissory Note

FIRST AMENDMENT TO 10% OID PROMISSORY NOTE This First Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on October 31, 2023 (the “Execution Date”) and effective as of October 24, 2023 (the “Effective Date”) by and between Healthy Extracts, Inc.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission File Number) (I

First Amendment to 10% OID Promissory Note

FIRST AMENDMENT TO 10% OID PROMISSORY NOTE This First Amendment to the 10% OID Promissory Note (this “Amendment”) is entered into on October 31, 2023 (the “Execution Date”) and effective as of October 23, 2023 (the “Effective Date”) by and between Healthy Extracts, Inc.

As filed with the Securities and Exchange Commission on October 24, 2023

As filed with the Securities and Exchange Commission on October 24, 2023 Registration No.

As filed with the Securities and Exchange Commission on October 6, 2023

As filed with the Securities and Exchange Commission on October 6, 2023 Registration No.

As filed with the Securities and Exchange Commission on September 14, 2023

As filed with the Securities and Exchange Commission on September 14, 2023 Registration No.

Supply Agreement with H&AD S.r.L. dated January 1, 2019, as amended

SUPPLY AGREEMENT This SUPPLY AGREEMENT (hereinafter the "Agreement"), is made and entered into this 1st day of January 2019 ("Effective Date"), as follows between 1)H&AD S.

Independent Contractor Agreement by and between the Company and Kevin “Duke” Pitts, dated October 1, 2019

Independent Contractor Agreement This Agreement is made between BergaMet NA LLC ("Client") with a principal place of business at 6445 South Tenaya Way Suite 110B, Las Vegas, NV 89113 and Kevin Pitts ("Contractor"), with a principal place of business at 3664 Christy Ridge Rd, Sedalia, CO 80135.

Licensing Agreement with Gelteq Ptd Ltd.

Key Terms – Private Label Agreement BETWEEN 1.Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, Australia (Gelteq); and 2.The Purchaser as set out in Schedule below (Purchaser). No. Item Details 1. Commencement Date 07/01/2021 2. Gelteq Details Entity Gelteq Pty Ltd Company Number ACN 619 501 254 Contact Person Simon Szewach Address c/o Level 7, 616-616 S

Line of Credit Promissory Note dated September 1, 2023

HEALTHY EXTRACTS INC. LINE OF CREDIT PROMISSORY NOTE Up to $82,500.00 September 1, 2023 FOR VALUE RECEIVED, Healthy Extracts Inc., a Nevada corporation, its assigns and successors (the “Company”), hereby promises to pay to Jay Decker, or his successors or assigns (the “Holder”), in immediately available funds, the total principal sum of up to Eighty Two Thousand Five Hundred Dollars ($82,500.00) (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

HE Def14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨Preliminary Information Statement ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) xDefinitive Information Statement HEALTHY EXTRACTS INC. (Name o

Certificate of Amendment of Articles of Incorporation

As filed with the Securities and Exchange Commission on August 25, 2023

As filed with the Securities and Exchange Commission on August 25, 2023 Registration No.

Articles of Incorporation of Grey Cloak Tech Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: xPreliminary Information Statement ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) ¨Definitive Information Statement HEALTHY EXTRACTS INC. (Name of Registra

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr

Supply Agreement with H&AD S.r.L. dated January 1, 2019, as amended

Amendment to Supply Agreement (00898762).DOCX SUPPLY AGREEMENT This SUPPLY AGREEMENT (hereinafter the "Agreement"), is made and entered into this 1st day of January 2019 ("Effective Date"), as follows between 1)H&AD S.r.L. (hereinafter "Supplier"). a limited company incorporated under the laws of Italy, with registered offices located at C/da Chiusi (Industrial Zone) snc, 89032 Bianco (R.C.), Cala

As filed with the Securities and Exchange Commission on July [•], 2023

As filed with the Securities and Exchange Commission on July [•], 2023 Registration No.

Licensing Agreement with Gelteq Ptd Ltd.

HE Gelteq License (Word Version for S-1) (02164249).DOCX Key Terms – Private Label Agreement BETWEEN 1.Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, Australia (Gelteq); and 2.The Purchaser as set out in Schedule below (Purchaser). No. Item Details 1. Commencement Date 07/01/2021 2. Gelteq Details Entity Gelteq Pty Ltd Company Number ACN 619 501 254 Co

As filed with the Securities and Exchange Commission on June 12, 2023

As filed with the Securities and Exchange Commission on June 12, 2023 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext

As filed with the Securities and Exchange Commission on April 11, 2023

As filed with the Securities and Exchange Commission on April 11, 2023 Registration No.

Lease Agreement for warehouse and distribution facility dated January 20, 2022

Microsoft Word - Healthy Extracts Inc. (7375 #125) Lease Agreement 01.20.22 LEASE AGREEMENT (Net) THIS LEASE AGREEMENT ("Lease") is made between Schnitzer Properties, LLC, an Oregon limited liability company ("Landlord"), and Healthy Extracts Inc., a Nevada corporation ("Tenant"), dated for reference purposes only, as January 20, 2022 (the "date of this Lease"). BASIC LEASE INFORMATION DESCRIPTION

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthy Extracts Inc.

Private Label Agreement with Whitney Johns, Inc. dated October 11, 2021

Noni Discovery Sales and Distr Agree (joint redline 4.9.21) (01839116-5).DOCX PRIVATE LABEL AGREEMENT This Private Label Agreement (this “Agreement”) is entered into on October 11th, 2021 (the “Effective Date”) by and between Healthy Extracts, a Nevada corporation (“HE”) and Whitney Johns, doing business as Whitney Johns, Inc. a S Corp corporation, (“WJ”). HE and WJ shall each be referred to herei

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts, Inc. (

Promissory Note dated March 20, 2023

EX-10.1 2 hyexex10z1.htm PROMISSORY NOTE DATED MARCH 20, 2023 PROMISSORY NOTE $330,000.00March 20, 2023 FOR VALUE RECEIVED, HEALTHY EXTRACTS, INC., a Nevada corporation (hereinafter called the “Borrower” or the “Company”) (Trading Symbol: HYEX), hereby promises to pay to the order of [Ÿ], or registered assigns (the “Holder”), in the form of lawful money of the United States of America, the princip

Common Stock Purchase Warrant dated March 20, 2023

Healthy Extracts Bruce Kaiman Warrant (final) (02114556-2).DOCX HEALTHY EXTRACTS INC. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“THE ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMEN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2023 HEALTHY EXTRACTS, INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

Supply Agreement with H&AD S.r.L. dated January 1, 2019, as amended

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthy Extracts, Inc.

As filed with the Securities and Exchange Commission on February 9, 2023

As filed with the Securities and Exchange Commission on February 9, 2023 Registration No.

Licensing Agreement with Gelteq Ptd Ltd.

EX-10.7 4 hyexex10z7.htm LICENSING AGREEMENT WITH GELTEQ PTD LTD.

Consulting Agreement with Robert Madden

Jeremy Hunsicker Form Consult (Draft) (02088618).DOCX HEALTHY EXTRACTS INC CONSULTING SERVICES AGREEMENT This Consulting Services Agreement (this “Agreement”) is entered into on June 1st, 2022 (the “Effective Date”) by and between Healthy Extracts Inc, a Nevada corporation company (the “Company”) and Robert Madden, an individual (the “Consultant”). Each of the Company and the Consultant shall be r

Code of Ethics

HE Code of Ethics (02099478).DOCX HEALTHY EXTRACTS, INC. CODE OF BUSINESS CONDUCT AND ETHICS Updated January 2023 Table of Contents 1 HEALTHY EXTRACTS, INC. CODE OF BUSINESS CONDUCT AND ETHICS 3 1.1 INTRODUCTION 3 2 GENERAL COMPLIANCE IS THE RESPONSIBILITY OF ALL EMPLOYEES 3 3 INDIVIDUAL RESPONSIBILITY TO THE COMPANY AND ITS STOCKHOLDERS 4 3.1 General Standards of Conduct 4 3.2 Equal Employment Op

Securities Purchase Agreement dated January 24, 2023

HYEX Walleye SPA (clean 1.24.23) (02097791-2).DOCX SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of January 24, 2023 between Healthy Extracts, Inc., a Nevada corporation (“Company”), and [·] (the “Investor” or the “Purchaser”). WHEREAS, the Investor wishes to purchase from the Company, and the Company wishes to sell and issue to the Investor, (i) a

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission F

Common Stock Purchase Warrant dated January 24, 2023

HYEX Walleye Warrant (clean 1.24.23) (02097793-2).DOCX WARRANT NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFE

10% OID Promissory Note dated January 24, 2023

HYEX Walleye Note (clean 1.24.23) (02097792-2).DOCX 10% OID PROMISSORY NOTE NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MA

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2023 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other (Commission (I.R.S. Employer jurisdiction of

Acquisition Agreement with Hyperion, L.L.C. and Online Publishing & Marketing, LLC dated January 13, 2023

ACQUISITION AGREEMENT by and between Healthy Extracts, Inc., a Nevada corporation, Green Valley Natural Solutions, LLC, a Nevada limited liability company, and Online Publishing & Marketing, LLC, a Nevada limited liability company, on the one hand and Hyperion, L.L.C., a Virginia limited liability company, Online Publishing & Marketing, LLC, a Virginia limited liability company, and the members of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION HEALTHY EXTRACTS INC.

CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of HEALTHY EXTRACTS INC. The undersigned hereby certifies: 1. The name of the Corporation is Healthy Extracts Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: ?Article 3, Authorized Stock: The Corporation has the authority to issue Two Billion Five Hundred Million (2,500,000,000) shares of common

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨Preliminary Information Statement ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) xDefinitive Information Statement HEALTHY EXTRACTS INC. (Name of Registra

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: xPreliminary Information Statement ?Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) ?Definitive Information Statement HEALTHY EXTRACTS INC. (Name of Registra

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION HEALTHY EXTRACTS INC.

CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of HEALTHY EXTRACTS INC. The undersigned hereby certifies: 1. The name of the Corporation is Healthy Extracts Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: ?Article 3, Authorized Stock: The Corporation has the authority to issue Two Billion Five Hundred Million (2,500,000,000) shares of common

Loan Agreement with Amazon Capital Services, Inc. entered into on October 7, 2022

LOAN AGREEMENT 1.Promise to Pay. The Business will pay to Amazon Capital Services, Inc. ("we", "us" or "our") the principal, interest, late interest, and any other charges and expenses due to us under this Loan Agreement, including charges and expenses in exercising any of our remedies, which altogether constitutes the "Loan". The Business must make periodic payments of interest and principal acco

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other (Commission (I.R.S. Employer jurisdiction of in

Securities Purchase Agreement dated May 25, 2022

Healthy Extracts Inc. SECURITIES PURCHASE AGREEMENT $154,000 Convertible Promissory Note SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is entered into on May 25, 2022 (the ?Effective Date?) by and between Healthy Extracts Inc., a Nevada corporation (the ?Company?), and Dan Bishop, an individual (the ?Purchaser?). The Company and the Purchaser shall each be ref

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-

Convertible Promissory Note dated May 25, 2022

NEITHER THIS CONVERTIBLE PROMISSORY NOTE NOR THE SHARES OF COMMON STOCK THAT MAY BE ACQUIRED UPON ITS CONVERSION HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada 333-202542 47-2594704 (State or other jurisdiction of incorporation) (Commission File N

Healthy Extracts Investor Presentation

Lease Agreement dated January 20, 2022

LEASE AGREEMENT (Net) THIS LEASE AGREEMENT (?Lease?) is made between Schnitzer Properties, LLC, an Oregon limited liability company (?Landlord?), and Healthy Extracts Inc.

FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extracts Inc. (E

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2022 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number

Common Stock Purchase Warrant dated February 10, 2022

HEALTHY EXTRACTS INC. THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (?THE ACT?), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTEN

Promissory Note dated February 22, 2022

PROMISSORY NOTE $200,000.00 February 22th, 2022 FOR VALUE RECEIVED, HEALTHY EXTRACTS INC., a Nevada corporation (hereinafter called the ?Borrower? or the ?Company?) (Trading Symbol: HYEX), hereby promises to pay to the order of Bruce Kaiman, or registered assigns (the ?Holder?), in the form of lawful money of the United States of America, the principal sum of $200,000.00, which amount is the $180,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

DEF 14C 1 hyex-20220107def14c.htm DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) x Definitive Information Stat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) o Definitive Information Statement HEALTHY EXTRACTS INC. (Name of Regis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy

September 8, 2021

September 8, 2021 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FIRST AMENDED FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FIRST AMENDED FORM 10-Q/A (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO September 3 , 2021

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

September 3, 2021

September 3, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO August 24 , 2021

August 24, 2021

August 24, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Extr

August 13, 2021

August 13, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO August 13 , 2021

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC.

EX1A-4 SUBS AGMT 3 grck-1aex4z1.htm EX1A-4 SUBS AGMT HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscr

August 6, 2021

August 6, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO August 6 , 2021

August 6, 2021

August 6, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Amendment No. 3 to Offering Statement on Form 1-A Filed August 6, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on July 26, 2021, the issuer has the following responses. Amendment No. 3 to Offering Statement on Form 1-A Plan of Distribution, page 15

Independent Contractor Agreement by and between the Company and Kevin “Duke” Pitts, dated October 1, 2019

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No.1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No.1 ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy

Certificate of Amendment of Articles of Incorporation

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47

Healthy Extracts Investor Presentation dated July 29, 2021

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO July 7 , 2021

July 7, 2021

July 7, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of up

July 7, 2021

July 7, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Amendment No. 2 to Offering Statement on Form 1-A Filed June 7, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on June 24, 2021, the issuer has the following responses. Amendment No. 2 to Offering Statement on Form 1-A Plan of Distribution, page 15 1. I

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC.

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscription Agreement”), intending to be legally bound, he

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

June 1, 2021

June 1, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Amendment No. 1 to Offering Statement on Form 1-A Filed May 7, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on May 20, 2021, the issuer has the following responses. Amendment No. 1 to Offering Statement on Form 1-A Business, page 25 1. We note your re

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC.

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscription Agreement”), intending to be legally bound, he

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO June 1 , 2021

June 1, 2021

June 1, 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connection with the proposed offering by the Company of up

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Healthy Ext

May 3, 2021

May 3, 2021 United States Securities and Exchange Commission Washington, D.C. 20549 Re: Healthy Extracts Inc. Offering Statement on Form 1-A Filed March 11, 2021 File No. 024-11481 In response to the comment letter issued by the Commission on April 7, 2021, the issuer has the following responses. Form 1-A Cover Page 1. Please disclose that your common stock is traded on the OTCQB and disclose the

Independent Contractor Agreement by and between the Company and Kevin “Duke” Pitts, dated October 1, 2019

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC.

HEALTHY EXTRACTS, INC. Form of Subscription Agreement to subscribe for Common Stock SUBSCRIPTION AGREEMENT HEALTHY EXTRACTS, INC. Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Ladies and Gentlemen: 1. Subscription. The person named on the signature page of this subscription agreement (the “Purchaser”) (this “Subscription Agreement”), intending to be legally bound, he

EX1A-6 MAT CTRCT

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Regulation A Offering Statement on Form 1-A of our report dated February 19, 2021, relating to the financial statements of Healthy Extracts, Inc., as of December 31, 2020 and 2019 and to all references to our firm included therein. Certified Public Accountants Lakewood, CO April 30, 2021

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

[Ÿ], 2021

EX1A-12 OPN CNSL 8 grck-1aex12z1.htm EX1A-12 OPN CNSL [Ÿ], 2021 Healthy Extracts, Inc. 6445 South Tenaya Way, Suite B110 Las Vegas, NV 89113 Re: Healthy Extracts, Inc. Registration Statement on Form 1-A for an offering by the Company of up to 100,000,000 shares of Common Stock Ladies and Gentlemen: We have acted as counsel to Healthy Extracts, Inc., a Nevada corporation (the “Company”), in connect

Promissory Note dated March 18, 2021

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Securities Purchase Agreement dated March 18, 2021

SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of March 18, 2021, by and between HEALTHY EXTRACTS INC.

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2021 HEALTHY EXTRACTS INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 4

- PART II AND III

U.S. SECURITIES AND EXCHANGE COMMISSION PART II – OFFERING CIRCULAR An offering statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary offering circular is subject to completion or amendment. These shares may not be sold nor may offers to buy be accepted before the off

Annual Report - 10-K

10-K 1 grck-2020123110k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 0

Employment Agreement by and between the Company and Kevin “Duke” Pitts, dated September 28, 2018

Certificate of Amendment of Articles of Incorporation

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2021 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cl

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

- DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) [ X ] Definitive Information Statement GREY CLOAK TECH INC. (Name o

Grey Cloak Tech Inc. 2020 Omnibus Stock Grant and Option Plan (the “Plan”)

GREY CLOAK TECH INC. 2020 OMNIBUS STOCK GRANT AND OPTION PLAN -1- TABLE OF CONTENTS Page SECTION 1. PURPOSE 1 SECTION 2. DEFINITIONS 1 (a) “Award” 1 (b) “Board of Directors” 1 (c) “Change in Control” 1 (d) “Code” 1 (e) “Committee” 1 (f) “Common-Law Employee” 2 (g) “Company” 2 (h) “Employee” 2 (i) “Exchange Act” 2 (j) “Exercise Price” 2 (k) “Fair Market Value” 2 (l) “Incentive Stock Option” or “ISO

- S-8

S-8 1 grck-20201001s8.htm S-8 As filed with the Securities and Exchange Commission on October 1, 2020 Registration No. 333- U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 Grey Cloak Tech Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation or Organization) 27

Form of Statutory Stock Option Agreement relating to options granted under the Plan

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.

Form of Non-Statutory Stock Option Agreement relating to options granted under the Plan

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.

- PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ X ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) [ ] Definitive Information Statement GREY CLOAK TECH INC. (Name o

Quarterly Report - 10-Q

10-Q 1 grck-2020063010q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission f

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex

Quarterly Report - FORM 10-Q FOR PERIOD ENDING SEPT 30, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CL

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CLOAK T

Share Exchange Agreement dated February 4, 2019 by and among Grey Cloak Tech Inc., BergaMet NA, LLC, and the Members of BergaMet

SHARE EXCHANGE AGREEMENT dated as of February 4, 2019 by and among Grey Cloak Tech Inc.

Form of Preferred Stock Conversion Agreement

PREFERRED STOCK CONVERSION AGREEMENT This Preferred Stock Conversion Agreement (this “Agreement”) is entered into on [•], 2019 by and between Grey Cloak Tech Inc.

Form of Note Satisfaction Agreement

NOTE SATISFACTION AGREEMENT This Note Satisfaction Agreement (this “Agreement”) is entered into on [Ÿ], 2019 (the “Effective Date”) by and between Grey Cloak Tech Inc.

Quarterly Report - FORM 10-Q FOR PERIOD ENDING MARCH 31, 2020

10-Q 1 grck-2019033110q.htm FORM 10-Q FOR PERIOD ENDING MARCH 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the t

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-

Share Exchange Agreement with Ultimate Brain Nutrients, LLC and its members

SHARE EXCHANGE AGREEMENT dated as of April , 2020 by and among Grey Cloak Tech Inc.

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2020 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-

Letter from Prager Metis CPAs LLC dated April 6, 2020

April 6, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements made by Grey Cloak Tech, Inc. under Item 4.01 of its Form 8-K dated April 7, 2020. We agree with the statements set forth in Item 4.01 insofar as the relate our Firm. We have no basis to agree or disagree with other statements made by the registrant contained in Item 4.01. Very trul

Share Exchange Agreement dated February 4, 2019 by and among Grey Cloak Tech Inc., BergaMet NA, LLC, and the Members of BergaMet

SHARE EXCHANGE AGREEMENT dated as of February 4, 2019 by and among Grey Cloak Tech Inc.

GRCK / GREY CLOAK TECH INC 10-K - Annual Report - FORM 10-K FOR PERIOD ENDING DECEMBER 31, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 4

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-

Unsecured Promissory Note, dated February 4, 2019, issued to William Bossung

PROMISSORY NOTE $61,875.91 February 4 , 2019 FOR VALUE RECEIVED, Grey Cloak Tech Inc., a Nevada corporation (“Borrower”), promises to pay to William Bossung (“Lender”) on or before February 4, 2020 (the “Maturity Date”) or earlier as provided herein, at any place designated by Lender, the principal amount of $61,875.91 (the “Principal Amount”), constituting all outstanding amounts previously advan

Unsecured Convertible Promissory Note, dated September 30, 2018, issued to William Bossung

THIS CONVERTIBLE PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

GRCK / GREY CLOAK TECH INC 10-Q (Quarterly Report) FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333-202542 GREY C

Grey Cloak Tech Inc. Completes Acquisition of BergaMet NA, LLC

Grey Cloak Tech Inc. Completes Acquisition of BergaMet NA, LLC Las Vegas, NV (February 7, 2019)- via New Media Wire -Grey Cloak Tech Inc (OTC: GRCK) is pleased to announce the completion of its acquisition of BergaMet NA, LLC. BergaMet is now a wholly-owned subsidiary of Grey Cloak Tech Inc. BergaMet imports, manufactures and distributes a proprietary line of products derived from the rare citrus

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2019 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

GRCK / GREY CLOAK TECH INC NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

Letter to Securities and Exchange Commission from Paritz & Company, P.A., dated October 29, 2018.

October 29, 2018 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements made by Grey Cloak Tech, Inc. under Item 4.01 of its Form 8-K dated October 29, 2018. We agree with the statements concerning our Firm in such Form 8-K. Very truly yours /s/Paritz & Company, PA

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number

GRCK / GREY CLOAK TECH INC / Gs Capital Partners, Llc - SCHEDULE 13G Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Grey Cloak Tech Inc (Name of Issuer) Common Stock (Title of Class of Securities) 397845207 (CUSIP Number) September 18, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number

GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED JUNE 30, 2018 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CLOAK T

GRCK / GREY CLOAK TECH INC NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.

GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333

GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333-202542 GREY CLOAK

Employment Agreement by and between the Company and William Bossung, dated October 17, 2017

EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into effective October 17, 2017 (the “Effective Date”) by and between Grey Cloak Tech Inc.

Convertible Promissory Note, dated October 27, 2017, issued to DT Growth Partners LLC

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note, dated October 31, 2017, issued to Power Up Lending Group Ltd.

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note, dated October 17, 2017, issued to Fred Covely

EX-10.36 7 grck-2017123110kex10z36.htm EXHIBIT 10.36 THIS CONVERTIBLE PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT OR AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE HOLDER. GREY CLOAK TECH INC. CONVERTIBLE PROMISSORY NOTE $30,000 Oc

Second Amendment to the Securities Purchase Agreement by and between the Company and Crown Bridge Partners, LLC, dated December 28, 2017

SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENT This Second Amendment to the Securities Purchase Agreement (the “Amendment”) is entered into and effective on December 28, 2017 (the “Effective Date”), by and between Grey Cloak Tech, Inc.

Convertible Promissory Note, dated December 11, 2017, issued to Auctus Fund, LLC

EX-10.40 11 grck-2017123110kex10z40.htm EXHIBIT 10.40 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A)

Convertible Promissory Note, dated October 4, 2017, issued to Adar Bays, LLC

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT”) US $50,000.

First Amendment to the Convertible Promissory Note issued to Crown Bridge Partners, LLC, dated December 28, 2017

FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE This First Amendment to the Convertible Promissory Note (the “Amendment”) is entered into on December 28, 2017 by and between Grey Cloak Tech, Inc.

Convertible Promissory Note, dated November 2, 2017, issued to Oakmore Opportunity Fund I LP

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

GRCK / GREY CLOAK TECH INC FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2017 (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex

Employment Agreement by and between the Company and Patrick Stiles, dated October 17, 2017

EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into effective October 17, 2017 (the “Effective Date”) by and between Grey Cloak Tech Inc.

GRCK / GREY CLOAK TECH INC NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2018 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47

GRCK / GREY CLOAK TECH INC DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [

GRCK / GREY CLOAK TECH INC CORRESP

February 16, 2018 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.

GRCK / GREY CLOAK TECH INC PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

GRCK / GREY CLOAK TECH INC CURRENT REPORT (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

Certificate of Amendment to the Articles of Incorporation

CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of GREY CLOAK TECH, INC. The undersigned hereby certifies: 1. The name of the Corporation is Grey Cloak Tech, Inc. 2. The articles have been amended as follows: Article 3 is amended and restated as follows: ?Article 3, Authorized Stock: The corporation has the authority to issue One Billion (1,000,000,000) shares of common stock, par value $0.0

GRCK / GREY CLOAK TECH INC CURRENT REPORT (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55572 (Commission File Number)

Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace

Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace LAS VEGAS, NV ? GRCK, (Marketwired) ? 11/15/17 ? Grey Cloak Tech Inc. (OTCQB: GRCK) today announces its purchase of the domain CBD.co. This announcement is made just as the Marijuana Business Conference (MJ BizCon) in Las Vegas is underway. Grey Cloak?s vision for CBD.co is to make it a media destination

GRCK / GREY CLOAK TECH INC CURRENT REPORT (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

GRCK / GREY CLOAK TECH INC DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [

GRCK / GREY CLOAK TECH INC NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.

GRCK / GREY CLOAK TECH INC FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2017 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 GREY CL

GRCK / GREY CLOAK TECH INC PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Grey Cloak Tech Completes Acquisition of Eqova Life Sciences

Grey Cloak Tech Completes Acquisition of Eqova Life Sciences LAS VEGAS, NV - (Marketwired) - 10/23/17 - Grey Cloak Tech Inc.

Amended and Restated Certificate of Designation of the Series A Convertible Preferred Stock, dated October 16, 2017.

AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF THE RIGHTS, PREFERENCES, PRIVILEGES AND RESTRICTIONS, WHICH HAVE NOT BEEN SET FORTH IN THE CERTIFICATE OF INCORPORATION OR IN ANY AMENDMENT THERETO, OF THE SERIES A CONVERTIBLE PREFERRED STOCK OF GREY CLOAK TECH INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

GREY CLOAK TECH CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number

Grey Cloak Tech Announces Letter of Intent to Acquire Eqova Life Sciences

Grey Cloak Tech Announces Letter of Intent to Acquire Eqova Life Sciences Grey Cloak Tech Inc.

GRCK / GREY CLOAK TECH INC / Oakmore Opportunity Fund I LP - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* GREY CLOAK TECH, INC. (Name of Issuer) Shares of Common Stock (Title of Class of Securities) 397845108 (CUSIP Number) September 26, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t

GRCK / GREY CLOAK TECH INC FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2017 (Quarterly Report)

10-Q 1 grck-2017063010q.htm FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the

GREY CLOAK TECH NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 000-55572 Washington, D.

Promissory Note issued by ShareRails, LLC to the Company, dated May 19, 2017

Exhibit 10.2 CONVERTIBLE PROMISSORY NOTE $100,000 May 19, 2017 FOR VALUE RECEIVED, ShareRails, LLC, a Delaware limited liability company, its assigns and successors (the ?Borrower?), hereby promises to pay to the order of Grey Cloak Tech Inc., a Nevada corporation (the ?Lender?), or assigns, in immediately available funds, the principal sum of One Hundred Thousand Dollars ($100,000). The principal

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47-2

Termination Agreement and Acknowledgement by and among the Company, ShareRails, LLC, Joseph Nejman, Dmitry Chourpo, Joseph Nejman, in his capacity as the “Selling Members’ Representative,” William Bossung, Fred Covely, Dimicho Pty. Ltd. and Covely Information Systems, dated May 19, 2017

Exhibit 10.1 TERMINATION AGREEMENT AND ACKNOWLEDGEMENT This Termination Agreement and Acknowledgement (?Termination Agreement?) is entered into on May 19, 2017 by and among Grey Cloak Tech Inc., a Nevada corporation (the ?Buyer?), ShareRails, LLC, a Delaware limited liability company (the ?Company?), Joseph Nejman, an individual (?Nejman?), Dmitry Chourpo, an individual (?Chourpo?), Joseph Nejman,

Development Services Agreement by and between the Company and Covely Information Systems, dated March 31, 2017

Development Services Agreement This Development Services Agreement (this ?Agreement?) is entered into effective March 31, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.

Development Services Agreement by and between the Company and Dimicho Pty. Ltd., dated March 31, 2017

Development Services Agreement This Development Services Agreement (this ?Agreement?) is entered into effective April 1, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.

Employment Agreement by and between the Company and William Bossung, dated March 31, 2017

EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into effective March 31, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.

Share Exchange Agreement by and among the Company, ShareRails, LLC, Joseph Nejman, Dmitry Chourpo and Joseph Nejman, in his capacity as the Selling Members’ Representative, dated March 31, 2017

SHARE EXCHANGE AGREEMENT dated as of March 31, 2017 by and among Grey Cloak Tech Inc.

GREY CLOAK TECH FORM 10-Q FOR PERIOD ENDED MARCH 31, 2017 (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 333-202542 GREY CLOAK

Employment Agreement by and between the Company and Joseph Nejman, dated March 31, 2017

EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is entered into effective March 31, 2017 (the ?Effective Date?) by and between Grey Cloak Tech Inc.

GRCK / GREY CLOAK TECH INC / Nejman Joseph - SC13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Grey Cloak Tech Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 397845108 (CUSIP Number) Brian A. Lebrecht c/o Clyde Snow & Sessions, P.C. 201 South Main Street, Suite 1300 Salt Lake City, UT 84111 (Name, Addr

GREY CLOAK TECH NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC File No: 333-201288 Washington, D.

Shareholders Agreement dated March 31, 2017.

SHAREHOLDERS AGREEMENT This Shareholders Agreement (this “Agreement”) is entered into on March 31, 2017 (the “Effective Date”) by and between Grey Cloak Tech Inc.

GRCK / GREY CLOAK TECH INC / Nejman Joseph - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Grey Cloak Tech Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 397845108 (CUSIP Number) Brian A. Lebrecht c/o Clyde Snow & Sessions, P.C. 201 South Main Street, Suite 1300 Salt Lake City, UT 84111 (Name, Addr

Convertible Promissory Note dated February 24, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION NOR THE SECURITIES COMMISSION OF ANY STATE.

GREY CLOAK TECH FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2016 (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 000-55572 Grey Cloak Tech Inc. (Ex

Convertible Promissory Note dated December 9, 2016

DEBT PURCHASE AND ASSIGNMENT AGREEMENT THIS DEBT PURCHASE AND ASSIGNMENT AGREEMENT (this "Agreement" ), is entered into on December 7, 2016, by and between Village Partners LLC (the "Assignor") and Coronado Ventures Number One, LLC (the "Assignee") (the Assignor and Assignee are collectively referred to as the "Parties" herein).

Convertible Promissory Note dated February 24, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION NOR THE SECURITIES COMMISSION OF ANY STATE.

Convertible Promissory Note dated November 17, 2016

NEITHER THIS NOTE NOR THE SECURITIES THAT MAY BE ISSUED BY THE COMPANY UPON CONVERSION HEREOF (COLLECTIVELY, THE ?SECURITIES?) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?1933 ACT?), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION.

Convertible Promissory Note dated January 23, 2017

Convertible Promissory Note dated January 23, 2017 - 1 - Convertible Promissory Note dated January 23, 2017 - 2 - Convertible Promissory Note dated January 23, 2017 - 3 - Convertible Promissory Note dated January 23, 2017 - 4 - Convertible Promissory Note dated January 23, 2017 - 5 - Convertible Promissory Note dated January 23, 2017 - 6 - Convertible Promissory Note dated January 23, 2017 - 7 - C

Convertible Promissory Note dated January 23, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated March 1, 2017

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated January 23, 2017

Convertible Promissory Note dated January 23, 2017 - 1 - Convertible Promissory Note dated January 23, 2017 - 2 - Convertible Promissory Note dated January 23, 2017 - 3 - Convertible Promissory Note dated January 23, 2017 - 4 - Convertible Promissory Note dated January 23, 2017 - 5 - Convertible Promissory Note dated January 23, 2017 - 6 - Convertible Promissory Note dated January 23, 2017 - 7 - C

Convertible Promissory Note dated March 10, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated March 7, 2017

Convertible Promissory Note dated March 7, 2017 -1- Convertible Promissory Note dated March 7, 2017 -2- Convertible Promissory Note dated March 7, 2017 -3- Convertible Promissory Note dated March 7, 2017 -4- Convertible Promissory Note dated March 7, 2017 -5- Convertible Promissory Note dated March 7, 2017 -6- Convertible Promissory Note dated March 7, 2017 -7- Convertible Promissory Note dated Ma

Convertible Promissory Note dated March 10, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated March 10, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated March 10, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated March 10, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note dated March 10, 2017

NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Certificate of Designation of the Series A Convertible Preferred Stock

CERTIFICATE OF DESIGNATION OF THE RIGHTS, PREFERENCES, PRIVILEGES AND RESTRICTIONS, WHICH HAVE NOT BEEN SET FORTH IN THE CERTIFICATE OF INCORPORATION OR IN ANY AMENDMENT THERETO, OF THE SERIES A CONVERTIBLE PREFERRED STOCK OF GREY CLOAK TECH INC.

GREY CLOAK TECH CURRENT REPORT (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number) 47

GREY CLOAK TECH NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-55572 CUSIP NUMBER: 889043105 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Re

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2017 GREY CLOAK TECH INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-202542 (Commission File Number)

Certificate of Amendment to the Articles of Incorporation, dated February 24, 2017

CERTIFICATE OF AMENDMENT to ARTICLES OF INCORPORATION of GREY CLOAK TECH, INC. The undersigned hereby certifies: 1. The name of the Corporation is Grey Cloak Tech, Inc. 2. The articles have been amended as follows: ?Article 3, Authorized Stock: The corporation has the authority to issue Five Hundred Million (500,000,000) shares of common stock, par value $0.001 per share, and Seventy Five Million

GREY CLOAK TECH DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [

GREY CLOAK TECH PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [ X ] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

GREY CLOAK TECH ESP

January 3, 2017 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.

GREY CLOAK TECH PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ X ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-5(d)(2)) [ ] Definitive Information Statement GREY CLOAK TECH, INC. (Name

Convertible Promissory Note dated September 7, 2016

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.